Caroline Tillett's Insider Trades & SAST Disclosures
Caroline Tillett's most recent trade in Kenvue Inc was a trade of 81,837 Stock Options done . Disclosure was reported to the exchange on March 10, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Caroline Tillett.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 81,837 | 81,837 | - | - | Stock Options | |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 9,807 | 9,807 | - | - | Restricted Stock Units | |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2025 | 4,267 | 8,533 | - | - | Restricted Stock Units | |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2025 | 4,267 | 45,657 | - | 0 | Common Stock | |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.04 per share. | 05 Mar 2025 | 1,529 | 44,128 | - | 23.0 | 35,228 | Common Stock |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 19,121 | 0 | - | - | Restricted Stock Units | |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 19,121 | 47,625 | - | 0 | Common Stock | |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 7,645 | 0 | - | - | Restricted Stock Units | |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 7,645 | 31,123 | - | 0 | Common Stock | |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.75 per share. | 13 Feb 2025 | 6,235 | 41,390 | - | 21.7 | 135,611 | Common Stock |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 3,000 | 24,490 | - | 0 | Common Stock | |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 3,000 | 2,994 | - | - | Restricted Stock Units | |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.75 per share. | 13 Feb 2025 | 2,619 | 28,504 | - | 21.7 | 56,963 | Common Stock |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.23 per share. | 13 Feb 2025 | 1,012 | 23,478 | - | 21.2 | 21,485 | Common Stock |
| Kenvue Inc | Tillett Caroline | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2024 | 1,498 | 2,994 | - | - | Restricted Stock Units | |
| Kenvue Inc | Tillett Caroline | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2024 | 1,498 | 22,257 | - | 0 | Common Stock | |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.08 per share. | 01 Dec 2024 | 767 | 21,490 | - | 24.1 | 18,469 | Common Stock |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 111,009 | 111,009 | - | - | Stock Options | |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 12,340 | 12,340 | - | - | Restricted Stock Units | |
| Kenvue Inc | Tillett Caroline | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2024 | 3,000 | 21,787 | - | 0 | Common Stock | |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2024 | 3,000 | 5,994 | - | - | Restricted Stock Units | |
| Kenvue Inc | Tillett Caroline | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.34 per share. | 13 Feb 2024 | 1,028 | 20,759 | - | 19.3 | 19,882 | Common Stock |
| Kenvue Inc | Tillett Caroline | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 21,321 | 21,321 | - | 0 | Common Stock | |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 21,321 | 0 | - | - | Restricted Stock Units | |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.67 per share. | 08 Feb 2024 | 6,961 | 14,360 | - | 19.7 | 136,923 | Common Stock |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 6,675 | 0 | - | - | Restricted Stock Units | |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 6,675 | 21,035 | - | 0 | Common Stock | |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.67 per share. | 08 Feb 2024 | 2,248 | 18,787 | - | 19.7 | 44,218 | Common Stock |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2023 | 39,705 | 39,705 | - | - | Stock Options | |
| Kenvue Inc | Tillett Caroline | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2023 | 4,324 | 4,324 | - | - | Restricted Stock Units | |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 113,957 | 113,957 | - | - | Stock Options | |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 75,541 | 75,541 | - | - | Stock Options | |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 74,422 | 74,422 | - | - | Stock Options | |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 73,348 | 73,348 | - | - | Stock Options | |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 23,158 | 23,158 | - | - | Restricted Stock Units | |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 21,321 | 21,321 | - | - | Restricted Stock Units | |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 19,121 | 19,121 | - | - | Restricted Stock Units | |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 8,994 | 8,994 | - | - | Restricted Stock Units | |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 7,645 | 7,645 | - | - | Restricted Stock Units | |
| Kenvue Inc | Caroline Tillett | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 6,675 | 6,675 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges